World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
19930
World Ranking
17268
National Ranking
1561

Derralynn Hughes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Derralynn Hughes sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 496 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Derralynn Hughes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Derralynn Hughes sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Derralynn Hughes is affiliated with the Royal Free London NHS Foundation Trust in the United Kingdom. Their research encompasses a broad range of topics primarily within medicine and biochemistry, genetics, and molecular biology, with a notable focus on rare diseases and metabolic disorders.

Their work extensively covers lysosomal storage disorders, a field supported by a large volume of publications. Key research topics also include carbohydrate chemistry and synthesis, Trypanosoma species research and its implications, cellular transport and secretion mechanisms, glycogen storage diseases and myoclonus, studies on chitinases and chitosanases, and Parkinson's disease mechanisms and treatments.

Notable recent papers by Hughes include:

  • Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study, 2020, BMJ Open
  • An expert consensus document on the management of cardiovascular manifestations of Fabry disease, 2020, European Journal of Heart Failure
  • Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial, 2021, The Lancet Neurology
  • Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial, 2021, The Lancet Neurology

Frequent coauthors in Hughes's research include Patrick Deegan, Raul Chertkoff, Aleš Linhart, Özlem Göker-Alpan, and Uma Ramaswami, indicating active collaboration networks in their field.

Hughes has published extensively in several venues, with significant contributions to Molecular Genetics and Metabolism, Orphanet Journal of Rare Diseases, bioRxiv (Cold Spring Harbor Laboratory), Journal of the American Society of Nephrology, and La Revue de Médecine Interne.

Their subfields of study highlight a multidisciplinary approach involving physiology, molecular biology, organic chemistry, epidemiology, and cell biology.

Best Publications

  • Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

    Dominique P Germain;Derralynn A Hughes;Kathleen Nicholls;Daniel G Bichet

  • Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.

    Daniel M. Sado;Steven K. White;Stefan K. Piechnik;Sanjay M. Banypersad

  • Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor.

    Iain Fraser;Derralynn Hughes;Siamon Gordon

  • Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

    D A Hughes;P M Elliott;J Shah;J Zuckerman

  • Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

    Derralynn A Hughes;Kathleen Nicholls;Suma P Shankar;Gere Sunder-Plassmann

  • Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

    Daniel M Sado;Andrew S Flett;Sanjay M Banypersad;Steven K White

  • Natural history of Fabry disease in females in the Fabry Outcome Survey

    P B Deegan;A F Baehner;M-Á Barba Romero;D A Hughes

  • Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

    Marieke Biegstraaten;Reynir Arngrímsson;Frederic Barbey;Lut Boks

  • Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse

    James Hopkinson-Woolley;Derralynn Hughes;Siamon Gordon;Paul Martin

  • The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock

    Richard Haworth;Nick Platt;Satish Keshav;Derralynn Hughes

  • Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

    Alisdair McNeill;Joana Magalhaes;Chengguo Shen;Kai-Yin Chau

  • Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.

    Maarten Arends;Christoph Wanner;Derralynn Hughes;Atul Mehta

  • Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.

    Alvina G Lai;Laura Pasea;Amitava Banerjee;Amitava Banerjee;Geoff Hall;Geoff Hall

  • Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse

    M.D. Witmer-Pack;D.A. Hughes;G. Schuler;L. Lawson

  • Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

    Jaymin S. Shah;Derralynn A. Hughes;Bhavesh Sachdev;Maite Tome

  • Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non‐lymphoid organs

    Derralynn A. Hughes;Iain P. Fraser;Siamon Gordon

  • Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey

    Perry Elliott;Robert Baker;Ferdinando Pasquale;Giovanni Quarta

  • Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.

    Michelle Beavan;Alisdair McNeill;Christos Proukakis;Derralynn A. Hughes

  • Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance

    Silvia Pica;Daniel M Sado;Viviana Maestrini;Marianna Fontana

  • The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.

    Elfrida R. Benjamin;Maria Cecilia Della Valle;Xiaoyang Wu;Evan Katz

Frequent Co-Authors

Atul Mehta
Atul Mehta The Royal Free Hospital
Roberto Giugliani
Roberto Giugliani Federal University of Rio Grande do Sul
Perry M. Elliott
Perry M. Elliott University College London
Raphael Schiffmann
Raphael Schiffmann Baylor University
James C. Moon
James C. Moon University College London
Daniel G. Bichet
Daniel G. Bichet University of Montreal
Ulla Feldt-Rasmussen
Ulla Feldt-Rasmussen University of Copenhagen
Christoph Wanner
Christoph Wanner University of Würzburg
Aleš Linhart
Aleš Linhart Charles University
William R. Wilcox
William R. Wilcox Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA doesn’t always require following the traditional MD route. There are numerous online degrees that provide quicker or alternative paths into healthcare. For those seeking to enter the nursing field rapidly, fast track medical programs like online LPN courses allow for faster entry into patient care roles.

Registered nurses looking to specialize can consider the msn to pmhnp online track, which helps RNs quickly become Psychiatric Mental Health Nurse Practitioners. Meanwhile, the healthcare sector also needs skilled administrators. Earning an online health management degree opens doors to leadership roles coordinating medical facilities and services.

For advanced opportunities, consider affordable online mha programs that provide in-depth preparation for executive positions in hospitals and related organizations. These varied online pathways offer flexible options for making a difference in healthcare without the traditional long timelines or high expenses.

Best Scientists Citing Derralynn Hughes

Trending Scientists

Recently Published Articles